Robert Curtis
20Patents
7h-index
18Co-inventors
66Inventor score
Filing activity: Feb 3, 1976 → Jan 22, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6530923B1 | Tissue removal methods and apparatus | Human Necessities | 153 | Expired |
| US6602204B2 | Intraoperative tissue treatment methods | Human Necessities | 38 | Expired |
| US4182739A | Blood oxygenator | Emerging Cross-Sectional Technologies | 29 | Expired |
| US4183961A | Method of oxygenating blood | Emerging Cross-Sectional Technologies | 27 | Expired |
| US4067696A | Blood oxygenator | Emerging Cross-Sectional Technologies | 18 | Expired |
| US8932324B2 | Redundant tissue closure methods and apparatuses | Human Necessities | 17 | Active |
| US10912778B2 | Methods for treatment of pulmonary hypertension | Human Necessities | 8 | Active |
| US10463815B2 | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents | Human Necessities | 2 | Active |
| US10525216B2 | Powder dispersion methods and devices | Human Necessities | 2 | Active |
| US10682476B2 | Powder inhaler, system and methods | Human Necessities | 1 | Active |
| USD1067457S1 | Cell therapy manufacturing cabinet | General | 1 | Active |
| US11491161B2 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | Human Necessities | 0 | Active |
| US11471623B2 | Powder dispersion methods and devices | Human Necessities | 0 | Active |
| US12364701B2 | PDE5 inhibitor powder formulations and methods relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US11491160B2 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | Human Necessities | 0 | Active |
| US11911390B2 | PDE5 inhibitor powder formulations and methods relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| USD1094763S1 | Cell therapy manufacturing receptacle | General | 0 | Active |
| US11806314B2 | PDE5 inhibitor powder formulations and methods relating thereto | Emerging Cross-Sectional Technologies | 0 | Active |
| US12263174B2 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders | Human Necessities | 0 | Active |
| USD1094762S1 | Cell therapy manufacturing apparatus | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.